136 related articles for article (PubMed ID: 9788770)
1. Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain.
Martin TJ; Hairston CT; Lutz PO; Harris LS; Porreca F
Eur J Pharmacol; 1998 Sep; 357(1):25-32. PubMed ID: 9788770
[TBL] [Abstract][Full Text] [Related]
2. Potent reinforcing effects of dihydroetorphine in rats.
Martin TJ; Kim SA; Harris LS; Smith JE
Eur J Pharmacol; 1997 Apr; 324(2-3):141-5. PubMed ID: 9145764
[TBL] [Abstract][Full Text] [Related]
3. Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
Martin TJ; Kim SA; Buechler NL; Porreca F; Eisenach JC
Anesthesiology; 2007 Feb; 106(2):312-22. PubMed ID: 17264726
[TBL] [Abstract][Full Text] [Related]
4. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain.
Lavand'homme PM; Eisenach JC
Pain; 1999 Mar; 80(1-2):31-6. PubMed ID: 10204715
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to analgesia and dependence liability by topical application of dihydroetorphine to hairless rats.
Ohmori S; Fang L; Kawase M; Saito S; Morimoto Y
Eur J Pharmacol; 2001 Jul; 423(2-3):157-66. PubMed ID: 11448480
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys.
Gerak LR; Gauthier CR; France CR
Psychopharmacology (Berl); 2003 Apr; 166(4):351-9. PubMed ID: 12601499
[TBL] [Abstract][Full Text] [Related]
7. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain.
Nielsen CK; Lewis RJ; Alewood D; Drinkwater R; Palant E; Patterson M; Yaksh TL; McCumber D; Smith MT
Pain; 2005 Nov; 118(1-2):112-24. PubMed ID: 16154696
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
Kamei J; Suzuki T; Nagase H
Neurosci Lett; 1996 Sep; 215(2):87-90. PubMed ID: 8888002
[TBL] [Abstract][Full Text] [Related]
9. Analgesic and Respiratory Depressant Effects of R-dihydroetorphine: A Pharmacokinetic-Pharmacodynamic Analysis in Healthy Male Volunteers.
Olofsen E; Boom M; Sarton E; van Velzen M; Baily P; Smith KJ; Oksche A; Dahan A; Niesters M
Anesthesiology; 2019 Dec; 131(6):1327-1339. PubMed ID: 31651529
[TBL] [Abstract][Full Text] [Related]
10. Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects.
Ohmori S; Morimoto Y
CNS Drug Rev; 2002; 8(4):391-404. PubMed ID: 12481194
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-allodynic effect between intraperitoneal thalidomide and morphine on rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Kim WM; Yoon MH; Park AR; Choi JI
Korean J Anesthesiol; 2013 Oct; 65(4):331-6. PubMed ID: 24228147
[TBL] [Abstract][Full Text] [Related]
14. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats.
Nichols ML; Bian D; Ossipov MH; Lai J; Porreca F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1339-45. PubMed ID: 8531101
[TBL] [Abstract][Full Text] [Related]
15. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
Shen KF; Crain SM
Brain Res; 1994 Feb; 636(2):286-97. PubMed ID: 8012813
[TBL] [Abstract][Full Text] [Related]
16. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models.
Christoph T; Kögel B; Strassburger W; Schug SA
Drugs R D; 2007; 8(1):51-7. PubMed ID: 17249849
[TBL] [Abstract][Full Text] [Related]
17. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines.
Raghavendra V; Tanga F; Rutkowski MD; DeLeo JA
Pain; 2003 Aug; 104(3):655-664. PubMed ID: 12927638
[TBL] [Abstract][Full Text] [Related]
18. Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain.
Ewan EE; Martin TJ
Anesthesiology; 2011 Mar; 114(3):624-32. PubMed ID: 21293250
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
Wu WR; Zheng JW; Li N; Bai HQ; Zhang KR; Li Y
Eur J Pharmacol; 1999 Feb; 366(2-3):261-9. PubMed ID: 10082208
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
Wu HE; Schwasinger ET; Hong JS; Tseng LF
Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
